We are live on ! Find out more
VFA

Virtus Fund Advisers Portfolio holdings

AUM $32.1M
1-Year Est. Return 39.5%
This Fund
S&P 500
This Quarter Est. Return
+5.84%
1 Year Est. Return
+39.5%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$10.2B
AUM Growth
+$370M
Cap. Flow
-$141M
Cap. Flow %
-1.39%
Top 10 Hldgs %
14%
Holding
622
New
136
Increased
89
Reduced
249
Closed
24

Top Buys

Rank Stock Value
1
RSG icon
Republic Services
RSG
+$92.7M
2
FRC
First Republic Bank
FRC
+$73.7M
3
BP icon
BP
BP
+$67.2M
4
KHC icon
Kraft Heinz
KHC
+$62.4M
5
HUM icon
Humana
HUM
+$56.3M

Top Sells

Rank Stock Value
1
EIX icon
Edison International
EIX
+$74.9M
2
LSI
Life Storage, Inc.
LSI
+$70.7M
3
BKU icon
Bankunited
BKU
+$62.6M
4
AWK icon
American Water Works
AWK
+$61.4M
5
SCG
Scana
SCG
+$57.7M

Sector Composition

Rank Sector Weight
1 Financials 16.41%
2 Industrials 15.8%
3 Healthcare 10.6%
4 Technology 10.4%
5 Energy 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GTHX
401
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$350K ﹤0.01%
+17,647
New +$379K
PRTK
402
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$350K ﹤0.01%
+19,580
New +$409K
AKBA icon
403
Akebia Therapeutics
AKBA
$267M
$349K ﹤0.01%
+23,459
New +$389K
BCRX icon
404
BioCryst Pharmaceuticals
BCRX
$2.1B
$349K ﹤0.01%
+71,081
New +$344K
SIOX
405
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$349K ﹤0.01%
+8,286
New +$372K
ACHN
406
DELISTED
Achillion Pharmaceuticals
ACHN
$349K ﹤0.01%
+121,264
New +$441K
BPMC
407
DELISTED
Blueprint Medicines
BPMC
$348K ﹤0.01%
+4,611
New +$324K
CYTK icon
408
Cytokinetics
CYTK
$10.1B
$348K ﹤0.01%
+42,645
New +$484K
CALA
409
DELISTED
Calithera Biosciences, Inc
CALA
$348K ﹤0.01%
+2,083
New +$533K
MLNT
410
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$348K ﹤0.01%
+4,411
New +$326K
ABEO icon
411
Abeona Therapeutics
ABEO
$311M
$346K ﹤0.01%
+874
New +$361K
DENN
412
DELISTED
Denny's
DENN
$346K ﹤0.01%
26,148
-2,220
-8% -$28.9K
IMGN
413
DELISTED
Immunogen Inc
IMGN
$346K ﹤0.01%
+53,977
New +$333K
EPZM
414
DELISTED
Epizyme, Inc
EPZM
$346K ﹤0.01%
+27,541
New +$400K
BLUE
415
DELISTED
bluebird bio
BLUE
$345K ﹤0.01%
+150
New +$305K
JNCE
416
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$344K ﹤0.01%
+26,948
New +$396K
MGNX icon
417
MacroGenics
MGNX
$268M
$343K ﹤0.01%
+18,057
New +$337K
TGTX icon
418
TG Therapeutics
TGTX
$8.27B
$343K ﹤0.01%
+41,833
New +$365K
BLCM
419
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$343K ﹤0.01%
+4,082
New +$400K
PEGA icon
420
Pegasystems
PEGA
$6.36B
$341K ﹤0.01%
14,456
-3,450
-19% -$92.6K
CTMX icon
421
CytomX Therapeutics
CTMX
$697M
$339K ﹤0.01%
+16,059
New +$333K
CLDX icon
422
Celldex Therapeutics
CLDX
$3.08B
$338K ﹤0.01%
+7,931
New +$340K
TCRT icon
423
Alaunos Therapeutics
TCRT
$3.79M
$338K ﹤0.01%
+545
New +$392K
TVRD
424
Tvardi Therapeutics
TVRD
$24.4M
$338K ﹤0.01%
+768
New +$350K
CRBP icon
425
Corbus Pharmaceuticals
CRBP
$156M
$337K ﹤0.01%
+1,581
New +$338K
15 16
17
18 19

Similar funds

VCM
V3 Capital Management Dallas, Texas $33.4M AUM 5.9% 1-Year Est. Return
CGI
Calixto Global Investors Coral Gables, Florida $30.7M AUM 111.27% 1-Year Est. Return
SFM
Spartan Fund Management Toronto, Ontario, Canada $30M AUM 11.98% 1-Year Est. Return
CIA
Compass Investment Advisers Portland, Oregon $34.4M AUM
SL
Stevard LLC Chicago, Illinois $26.8M AUM 42.43% 1-Year Est. Return
OAM
Origin Asset Management London, United Kingdom $43.5M AUM 31.63% 1-Year Est. Return
MFAM
M Financial Asset Management Portland, Oregon $20.6M AUM 4.99% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Virtus Fund Advisers's Q4 2017 Portfolio in Review

As of Q4 2017, Virtus Fund Advisers held 622 positions worth $10.2B, up 3.8% from $9.81B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Virtus Fund Advisers's Q4 2017 filing shows 136 new, 89 increased, 249 reduced and 24 closed positions. Its largest new stake was BP: 1,855,977 shares worth $71.4M. The largest sale was Edison International, an estimated $74.9M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Industrials and Healthcare.

  • Virtus Fund Advisers's largest Q4 2017 buy was BP: 1,855,977 shares worth $71.4M.
  • Virtus Fund Advisers added most to Republic Services in Q4 2017, an estimated $92.7M increase.
  • Virtus Fund Advisers's biggest Q4 2017 reduction was Public Storage, cutting an estimated $53.8M.
  • Virtus Fund Advisers fully exited Edison International in Q4 2017, selling an estimated $74.9M.
  • Virtus Fund Advisers's ten largest holdings make up 14% of its $10.2B portfolio in Q4 2017.
  • Virtus Fund Advisers opened 136 new positions and closed 24 in Q4 2017.
  • Virtus Fund Advisers's portfolio value rose 3.8% quarter-over-quarter to $10.2B.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.